首页
学习
活动
专区
工具
TVP
发布
精选内容/技术社群/优惠产品,尽在小程序
立即前往

让更多人用上基因疗法,FDA指出这些方向|全球监管动态

▎药明康德内容团队编辑

参考资料:

[1] Remarks by Commissioner Robert Califf to the 2023 Food and Drug Law Institute (FDLI) Annual Conference. Retrieved May 19, 2023, from https://www.fda.gov/news-events/speeches-fda-officials/remarks-commissioner-robert-califf-2023-food-and-drug-law-institute-fdli-annual-conference-05172023

[2] FDA official offers insights into whether gene therapy makers could use common manufacturing process. Retrieved May 19, 2023, from https://www.statnews.com/2023/05/19/marks-gene-therapy-common-manufacturing/

[3] FDA's Peter Marks talks reimbursement of gene therapies that win accelerated approval. Retrieved May 19, 2023, from https://endpts.com/peter-marks-talks-reimbursement-of-gene-therapies-that-win-accelerated-approval/

[4] Even FDA's Peter Marks is worried about the commercial viability of gene and cell therapies. Retrieved May 19, 2023, from https://endpts.com/even-fdas-peter-marks-is-worried-about-the-commercial-viability-of-gene-and-cell-therapies/

  • 发表于:
  • 原文链接https://kuaibao.qq.com/s/20230522A00TUW00?refer=cp_1026
  • 腾讯「腾讯云开发者社区」是腾讯内容开放平台帐号(企鹅号)传播渠道之一,根据《腾讯内容开放平台服务协议》转载发布内容。
  • 如有侵权,请联系 cloudcommunity@tencent.com 删除。

扫码

添加站长 进交流群

领取专属 10元无门槛券

私享最新 技术干货

扫码加入开发者社群
领券